Most recently Archimbaud served as senior vice president, life sciences for the Societe Generale de Financement (SGF) du Quebec, a government-owned investment entity contributing to the development of life sciences both locally and internationally. Prior to SGF, Archimbaud was the president and chief executive officer of Kinetek Pharmaceuticals Inc. Archimbaud also held progressively senior roles in sales, marketing, business development and licensing in his 20 years with Ipsen Beaufour, a European pharmaceutical company.
“We are pleased to have Mr. Archimbaud join the Board of Directors of MedMira. As we aggressively move our business strategy forward, Mr. Archimbaud’s in-depth industry knowledge and experience in developing strategic partnerships will be invaluable to our Company,” said James Smith, chairman of the board, MedMira.
“The Board thanks Mr. Harris for his contribution to MedMira during his tenure as a Board member,” said Smith.